1.21
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.25
Aprire:
$1.25
Volume 24 ore:
166.40K
Relative Volume:
0.34
Capitalizzazione di mercato:
$55.31M
Reddito:
-
Utile/perdita netta:
$-40.56M
Rapporto P/E:
-1.0342
EPS:
-1.17
Flusso di cassa netto:
$-35.28M
1 W Prestazione:
+0.83%
1M Prestazione:
-24.38%
6M Prestazione:
-21.94%
1 anno Prestazione:
-67.86%
Pds Biotechnology Corporation Stock (PDSB) Company Profile
Nome
Pds Biotechnology Corporation
Settore
Industria
Telefono
800-208-3343
Indirizzo
303A COLLEGE ROAD EAST, PRINCETON
Confronta PDSB con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
PDSB
Pds Biotechnology Corporation
|
1.21 | 52.57M | 0 | -40.56M | -35.28M | -1.17 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Pds Biotechnology Corporation Stock (PDSB) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2022-11-01 | Iniziato | B. Riley Securities | Buy |
2021-06-28 | Iniziato | Cantor Fitzgerald | Overweight |
2020-11-10 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
2020-05-27 | Iniziato | Alliance Global Partners | Buy |
2020-03-09 | Iniziato | Noble Capital Markets | Outperform |
2019-10-24 | Iniziato | Chardan Capital Markets | Buy |
Mostra tutto
Pds Biotechnology Corporation Borsa (PDSB) Ultime notizie
Is PDS Biotechnology Corporation stock a good hedge against inflationSuperior risk-adjusted returns - jammulinksnews.com
PDS Biotechnology Corporation Stock Analysis and ForecastDynamic profit expansion - Autocar Professional
What analysts say about PDS Biotechnology Corporation stockMarket-crushing stock picks - Autocar Professional
PDS Biotechnology Publishes Versamune® HPV Abstracts at ASCO - MSN
What drives PDS Biotechnology Corporation stock priceFree Stock Movement Tracking - jammulinksnews.com
How PDS Biotechnology Corporation stock performs during market volatilityHigh Yield Stock Selection - Newser
Is PDS Biotechnology Corporation a good long term investmentSuperior capital gains - PrintWeekIndia
Why PDS Biotechnology Corporation stock attracts strong analyst attentionFree Stock Market Knowledge Sharing - Newser
What makes PDS Biotechnology Corporation stock price move sharplyFree Access to Investment Community - Newser
PDS Biotechnology stock advances as Phase 2 trial meets expansion criteria - Investing.com Nigeria
PDS Biotechnology completes recruitment for stage one of colorectal cancer trial - Yahoo Finance
PDS Biotechnology Corporation Announces Colorectal Cancer Cohort of Phase 2 Clinical Trial with PDS01ADC Met Criteria for Expansion to Stage 2 Following Positive Stage 1 Results - MarketScreener
PDS Biotechnology stock rises after trial meets criteria for expansion By Investing.com - Investing.com Nigeria
PDS Biotechnology stock rises after trial meets criteria for expansion - Investing.com Australia
PDS Biotech's PDS01ADC: A Breakthrough in Cytokine Therapy for Metastatic Colorectal Cancer - AInvest
PDS Biotech Announces Colorectal Cancer Cohort of Phase 2 Clinical Trial with PDS01ADC Met Criteria for Expansion to Stage 2 Following Positive Stage 1 Results - The Manila Times
PDS Biotech Achieves Crucial Phase 2 Milestone: Colorectal Cancer Drug Shows Promising Early Results - Stock Titan
PDS Biotechnology (PDSB) Retains "Buy" Rating with Price Target Unchanged | PDSB Stock News - GuruFocus
PDSB’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com
Transcript : PDS Biotechnology CorporationSpecial Call - MarketScreener
PDS Biotechnology holds a conference call - TipRanks
PDS Biotechnology (NASDAQ:PDSB) Stock Rating Lowered by Wall Street Zen - Defense World
HC Wainwright Issues Pessimistic Estimate for PDSB Earnings - Defense World
PDS Biotechnology Co. (NASDAQ:PDSB) Shares Sold by Millennium Management LLC - Defense World
Two Sigma Investments LP Raises Stock Holdings in PDS Biotechnology Co. (NASDAQ:PDSB) - Defense World
PDS Biotechnology (NASDAQ:PDSB) Receives Buy Rating from HC Wainwright - Defense World
PDS Biotech expands equity incentive plan By Investing.com - Investing.com Canada
PDS Biotech expands equity incentive plan - Investing.com
Pds Biotechnology Corporation Azioni (PDSB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):